Fermicon 7/Somnugen (Canada)
This page contains information on Fermicon 7/Somnugen for veterinary use.The information provided typically includes the following:
- Fermicon 7/Somnugen Indications
- Warnings and cautions for Fermicon 7/Somnugen
- Direction and dosage information for Fermicon 7/Somnugen
Fermicon 7/somnugen
This treatment applies to the following species:Manufacturer: Boehringer
BOEHRINGER INGELHEIM (CANADA) LTD.Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C & D-Haemophilus Somnus Bacterin-Toxoid
Veterinary Use Only
Fermicon 7/Somnugen Indications
For vaccination of healthy, susceptible cattle as an aid in the reduction of diseases caused by Clostridium chauvoei, Cl. septicum, Cl. novyi, Cl. sordellii, Cl. perfringens types C and D, and Haemophilus somnus.Dosage
Using aseptic technique, inject 5 mL intramuscularly or subcutaneously. Repeat in 21 to 28 days and once annually.Precautions
Store in dark at 2-7°C. Do not freeze. Shake well. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur. Antidote: Epinephrine.Preservative
Phenol.Manufactured by: Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri 64506 U.S.A.
U.S. Veterinary License No. 124
Manufactured for: Boehringer Ingelheim (Canada) Ltd., Burlington, Ontario L7L 5H4
|
10 Doses/50 mL |
18707-05 |
|
50 Doses/250 mL |
18708-05 |
Nac No.
123002035180 SOUTH SERVICE ROAD, BURLINGTON, ON, L7L 5H4
| Customer Care No.: | 800-567-1885 | |
| Technical Services No.: | 1-877-565-5501 | |
| Website: | www.boehringer-ingelheim.ca |
 |
Every effort has been made to ensure the accuracy of the Fermicon 7/Somnugen information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert. |
